Advertisement

Biological performance of a promising Kefiran-biopolymer with potential in regenerative medicine applications: a comparative study with hyaluronic acid

  • Hajer Radhouani
  • Cristiana Gonçalves
  • F. Raquel Maia
  • Joaquim M. Oliveira
  • Rui L. Reis
Biomaterials Synthesis and Characterization Original Research
  • 169 Downloads
Part of the following topical collections:
  1. Biomaterials Synthesis and Characterization

Abstract

Kefiran from kefir grains, an exopolysaccharide (EPS) produced by lactic acid bacteria (LAB), has received an increasing interest because of its safe status. This natural biopolymer is a water-soluble glucogalactan with probed health-promoting properties. However, its biological performance has yet to be completely recognized and properly exploited. This research was carried out to evaluate the in vitro antioxidant and the in vitro anti-inflammatory properties of Kefiran biopolymer. Regarding antioxidant activity, the results demonstrated that the Kefiran extract possessed the strongest reducing power and superoxide radical scavenging, over hyaluronic acid (HA, gold standard viscosupplementation treatment). This exopolysaccharide showed a distinct antioxidant performance in the majority of in vitro working mechanisms of antioxidant activity comparing to HA. Moreover, Kefiran presented an interesting capacity to scavenge nitric oxide radical comparing to the gold standard that did not present any potency. Finally, the cytotoxic effects of Kefiran extracts on hASCs were also performed and demonstrated no cytotoxic response, ability to improve cellular function of hASCs. This study demonstrated that Kefiran represented a great scavenger for reactive oxygen and nitrogen species and showed also that it could be an excellent candidate to promote tissue repair and regeneration.

Notes

Acknowledgements

Hajer Radhouani, Cristiana Gonçalves and F. Raquel Maia were supported by grants with reference SFRH/BPD/100957/2014, SFRH/BPD/94277/2013 and SFRH/BPD/117492/2016, respectively of Fundação para a Ciência e a Tecnologia (FCT) from Portugal. JM Oliveira also would like to thank FCT for the fund provided under the program Investigador FCT 2015 (IF/01285/2015).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Zhang W, Ouyang H, Dass CR, Xu J. Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res. 2016;4:15040  https://doi.org/10.1038/boneres.2015.40. CrossRefGoogle Scholar
  2. 2.
    Ondresik M, Maia FRA, Morais AD, Gertrudes AC, Bacelar AHD, Correia C, et al. Management of knee osteoarthritis. Current status and future trends. Biotechnol Bioeng. 2017;114(4):717–39.  https://doi.org/10.1002/bit.26182. CrossRefGoogle Scholar
  3. 3.
    Mushtaq S, Choudhary R, Scanzello CR. Non-surgical treatment of osteoarthritis-related pain in the elderly. Curr Rev Musculoskelet Med. 2011;4(3):113–22.  https://doi.org/10.1007/s12178-011-9084-9. CrossRefGoogle Scholar
  4. 4.
    Kristjansson B, Honsawek S. Current perspectives in mesenchymal stem cell therapies for osteoarthritis. Stem Cells Int. 2014. 2014:1-13. Artn 194318  https://doi.org/10.1155/2014/194318.
  5. 5.
    Mao AS, Mooney DJ. Regenerative medicine: current therapies and future directions. Proc Natl Acad Sci USA. 2015;112(47):14452–9.  https://doi.org/10.1073/pnas.1508520112. CrossRefGoogle Scholar
  6. 6.
    Fisher MB, Mauck RL. Tissue engineering and regenerative medicine: recent innovations and the transition to translation. Tissue Eng Part B Rev. 2013;19(1):1–13.  https://doi.org/10.1089/ten.TEB.2012.0723. CrossRefGoogle Scholar
  7. 7.
    Edgar L, McNamara K, Wong T, Tamburrini R, Katari R, Orlando G. Heterogeneity of scaffold biomaterials in tissue engineering. materials (Basel). 2016;9(5):332–353.  https://doi.org/10.3390/ma9050332.
  8. 8.
    El-Sherbiny IM, Yacoub MH. Hydrogel scaffolds for tissue engineering: progress and challenges. Glob Cardiol Sci Pract. 2013;2013(3):316–42.  https://doi.org/10.5339/gcsp.2013.38. CrossRefGoogle Scholar
  9. 9.
    Prestwich GD. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. J Control Release. 2011;155(2):193–9.  https://doi.org/10.1016/J.Jconrel.2011.04.007. CrossRefGoogle Scholar
  10. 10.
    Borzacchiello A, Russo L, Malle BM, Schwach-Abdellaoui K, Ambrosio L. Hyaluronic acid based hydrogels for regenerative medicine applications. Biomed Res Int. 2015;2015:871218  https://doi.org/10.1155/2015/871218. CrossRefGoogle Scholar
  11. 11.
    Fakhari A, Berkland C. Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment. Acta Biomater. 2013;9(7):7081–92.  https://doi.org/10.1016/j.actbio.2013.03.005. CrossRefGoogle Scholar
  12. 12.
    Elsayed EA, Farooq M, Dailin D, El-Enshasy HA, Othman NZ, Malek R, et al. In vitro and in vivo biological screening of kefiran polysaccharide produced by Lactobacillus kefiranofaciens. Biomed Res-India. 2017;28(2):594–600.Google Scholar
  13. 13.
    Kooiman P. The chemical structure of kefiran, the water-soluble polysaccharide of the kefir grain. Carbohydr Res. 1968;7:200–1.  https://doi.org/10.1016/S0008-6215(00)81138-6. CrossRefGoogle Scholar
  14. 14.
    de Oliveira Leite AM, Miguel MA, Peixoto RS, Rosado AS, Silva JT, Paschoalin VM. Microbiological, technological and therapeutic properties of kefir: a natural probiotic beverage. Braz J Microbiol. 2013;44(2):341–9.  https://doi.org/10.1590/S1517-83822013000200001. CrossRefGoogle Scholar
  15. 15.
    Manoto SL, Maepa MJ, Motaung SK. Medical ozone therapy as a potential treatment modality for regeneration of damaged articular cartilage in osteoarthritis. Saudi. J of Biol Sci. 2018;25(4):672–79.  https://doi.org/10.1016/j.sjbs.2016.02.002. CrossRefGoogle Scholar
  16. 16.
    Radhouani H, Gonçalves C, Oliveira JM, Reis RL. Kefiran for use in regenerative medicine and/ortissue engineering. A4TEC - Association for the advancement of tissue engineering and cell basedtechnologies & therapies. 2018; WO/2018/042405.Google Scholar
  17. 17.
    Qi H, Zhang Q, Zhao T, Hu R, Zhang K, Li Z. In vitro antioxidant activity of acetylated and benzoylated derivatives of polysaccharide extracted from Ulva pertusa (Chlorophyta). Bioorg & Med Chem Lett. 2006;16:2441–5.  https://doi.org/10.1016/j.bmcl.2006.01.076. CrossRefGoogle Scholar
  18. 18.
    Singhal M, Ratra P. Antioxidant activity, total flavonoid and total phenolic content of musa acuminate peel extracts. Glob J Pharmacol. 2013;7(2):118–22.Google Scholar
  19. 19.
    El SN, Karakaya S. Radical scavenging and iron-chelating activities of some greens used as traditional dishes in Mediterranean diet. Int J Food Sci Nutr. 2004;55(1):67–74.  https://doi.org/10.1080/09637480310001642501. CrossRefGoogle Scholar
  20. 20.
    Nagai T, Nagashima T, Suzuki N, Inoue R. Antioxidant activity and angiotensin I-converting enzyme inhibition by enzymatic hydrolysates from bee bread. Z Naturforsch C. 2005;60(1-2):133–8.CrossRefGoogle Scholar
  21. 21.
    Nishikimi M, Roa NA, Yogi K. Measurement of superoxide dismutase. Biochem Biophys Res Commun. 1972;46:849–54.CrossRefGoogle Scholar
  22. 22.
    Naithani V, Singhal AK, Chaudhary M. Comparative evaluation of metal chelating, antioxidant and free radical scavenging activity of TROIS and six products commonly used to control pain and inflammation associated with arthritis. Int J Drug Dev & Res. 2011;3(4):208–16.Google Scholar
  23. 23.
    Ye SH, Liu F, Wang JH, Wang H, Zhang MP. Antioxidant activities of an exopolysaccharide isolated and purified from marine Pseudomonas PF-6. Carbohyd Polym. 2012;87(1):764–70.  https://doi.org/10.1016/j.carbpol.2011.08.057. CrossRefGoogle Scholar
  24. 24.
    Perez-Torres I, Guarner-Lans V, Rubio-Ruiz ME. Reductive stress in inflammation-associated diseases and the pro-oxidant effect of antioxidant agents. Int J Mol Sci. 2017;18(10):2098–2126.  https://doi.org/10.3390/ijms18102098.
  25. 25.
    Aparadh VT, Naik VV, Karadge BA. Antioxidantive properties (TPC, DPPH, FRAP, Metal chelating ability, reducing power and TAC) within some cleome species. Ann di Bot. 2012;2:49–56.Google Scholar
  26. 26.
    Liang TW, Tseng SC, Wang SL. Production and characterization of antioxidant properties of exopolysaccharide(s) from peanibacillus mucilaginosus TKU032. Mar Drugs 2016;14(2):40–52.  https://doi.org/10.3390/md14020040.
  27. 27.
    Flora SJ. Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure. Oxid Med Cell Longev. 2009;2(4):191–206.  https://doi.org/10.4161/oxim.2.4.9112. CrossRefGoogle Scholar
  28. 28.
    Wang J, Hu S, Nie S, Yu Q, Xie M. Reviews on mechanisms of in vitro antioxidant activity of polysaccharides. Oxid Med Cell Longev. 2016;2016:5692852  https://doi.org/10.1155/2016/5692852. CrossRefGoogle Scholar
  29. 29.
    Liu SH, Sun SW, Tian ZF, Wu JY, Li XL, Xu CP. Antioxidant and hypoglycemic activities of exopolysaccharide by submerged culture of inocutus hispidus. Indian J Pharm Sci. 2015;77(3):361–5.CrossRefGoogle Scholar
  30. 30.
    Wang Y, Yang Z, Wei X. Antioxidant activities potential of tea polysaccharide fractions obtained by ultra filtration. Int J Biol Macromol. 2012;50(3):558–64.  https://doi.org/10.1016/j.ijbiomac.2011.12.028. CrossRefGoogle Scholar
  31. 31.
    Guo S, Mao W, Han Y, Zhang X, Yang C, Chen Y, et al. Structural characteristics and antioxidant activities of the extracellular polysaccharides produced by marine bacterium Edwardsiella tarda. Bioresour Technol. 2010;101(12):4729–32.  https://doi.org/10.1016/j.biortech.2010.01.125. CrossRefGoogle Scholar
  32. 32.
    Li HF, Xu JA, Liu YM, Ai SB, Qin F, Li ZW, et al. Antioxidant and moisture-retention activities of the polysaccharide from Nostoc commune. Carbohyd Polym. 2011;83(4):1821–7.  https://doi.org/10.1016/j.carbpol.2010.10.046. CrossRefGoogle Scholar
  33. 33.
    Driessche TrsV, Guisset J-L, Petiau-deVries GM. The redox state and circadian rhythms. Springer; Springer Netherlands 2000; XII, 284.  https://doi.org/10.1007/978-94-015-9556-8.
  34. 34.
    Gutierrez RM, Baez EG. Evaluation of antidiabetic, antioxidant and antiglycating activities of the Eysenhardtia polystachya. Pharmacogn Mag. 2014;10(Suppl 2):S404–18.  https://doi.org/10.4103/0973-1296.133295. CrossRefGoogle Scholar
  35. 35.
    Popa E, Reis R, Gomes M. Chondrogenic phenotype of different cells encapsulated in kappa-carrageenan hydrogels for cartilage regeneration strategies. Biotechnol Appl Biochem. 2012;59(2):132–41.  https://doi.org/10.1002/bab.1007. CrossRefGoogle Scholar
  36. 36.
    Santo VE, Popa EG, Mano JF, Gomes ME, Reis RL. Natural assembly of platelet lysate-loaded nanocarriers into enriched 3D hydrogels for cartilage regeneration. Acta Biomater. 2015;19:56–65.  https://doi.org/10.1016/j.actbio.2015.03.015. CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.3B’s Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da GandraUniversity of MinhoGuimarãesPortugal
  2. 2.ICVS/3B’s–PT Government Associate LaboratoryBraga/GuimarãesPortugal
  3. 3.The Discoveries Centre for Regenerative and Precision MedicineHeadquarters at University of Minho, AveparkGuimarãesPortugal

Personalised recommendations